Latest filing published 08 Apr 2024 for NGM Biopharmaceuticals INC.
Insider track record
No signal scores available.
Irene Perlich: trading record in brief
Irene Perlich is a declared insider of NGM Biopharmaceuticals Inc, with filings sourced from SEC (Form 4). Between 16 January 2024 and 5 April 2024, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 8 April 2024, the filings show a transaction in NGM Biopharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Irene Perlich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,284 sharesCommon StockSEC:0000950170-24-042607:0
- 1,025 shares@ US$1.34100.0% of flowCommon StockSEC:0001415889-24-001543:0
2 of 2 declarations